Not sure what #MicroblogMondays is? Read the inaugural post which explains the idea and how you can participate too.
Breaking my habit of forwarding articles to others with this one. Especially as this is my arena.
Over the past 20 yrs, there's been great advances in technology related to biology. From sequencing to drug development to the rise in bioinformatics, there's been a big shift to genome-wide analysis and a push towards translational medicine. Hot topics right now include CRISPR-Cas system, RNA seq, immunotherapies linked with the microbiome and biomarkers.
So what does any of this have to do with infertility? Until recently, nothing. Simply because this wasn't an area researchers were actively investigating. One major downside of a taboo disease is that there's no funding for these investigations. And no funding means that the 1 in 8 impacted by this disease (1 in 4 globally) are relying on IVF and fertility drugs as a form of treatment/cure. That investigations into the underlying causes for diseases such as polycystic ovarian syndrome (PCOS), endometriosis, premature ovarian failure and immunoissues such as clotting disorders remain poorly understood.
This morning, I opened my email and found this article. Billed as building a smart tampon, NextGen Jane is a diagnostic start-up that is geared towards women's health. All focusing on biomarkers that can be extracted from the blood we release during menstruation.
Granted, there's a lot of work to be done. And there will be a lot of wrinkles and knots to smooth out. But, this is the first shift. A long overdue shift towards actually being proactive to identify this disorders early, allowing for early intervention and maybe, just maybe, actual treatment.
Should You Tell People About Your Infertility?
22 hours ago